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Abstract
Purpose—To examine, at the population level, health behaviors, comorbidities, and health-
related quality of life among colorectal cancer (CRC) survivors compared with other cancer 
survivors and persons without cancer.
Methods—We used data from the 2009 and 2010 Behavioral Risk Factor Surveillance System 
cancer survivor modules. We calculated descriptive statistics, conducted chi-square tests for 
comparisons, and used multivariable logistic regression analysis to compare CRC survivors with 
other cancer survivors and persons without cancer.
Results—Of the 52,788 cancer survivors included in this analysis, 4001 reported being CRC 
survivors. When compared with other cancer survivors, CRC survivors reported higher 
percentages of obesity and lack of physical activity; however, they had lower levels of current 
smoking. Adjusted results show that CRC survivors were significantly more likely to report lack 
of physical activity, fair/poor health, and other chronic health conditions compared with persons 
without a cancer diagnosis. Conversely, CRC survivors reported lower levels of current smoking 
than persons without cancer.
Conclusions—CRC survivors have a higher proportion of heath conditions and behaviors that 
may significantly increase their risks for recurrence or development of a second cancer. Targeted 
interventions to address these health issues should be considered.
Background
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second 
leading cause of cancer death among cancers affecting both men and women in the United 
States.1 Advances in early detection and treatment have increased cancer survival2: the 
overall 5-year survival rate for those diagnosed with CRC is 64%.3,4 In the United States, 
there are approximately 1.2 million CRC survivors.3 As the CRC survivor population grows, 
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more attention must be paid to their long-term care and follow-up. Clinical studies of cancer 
survivors have shown that comorbidities, such as obesity, and health behaviors, such as 
physical inactivity and heavy smoking, greatly influence overall quality of life and long-
term survival of CRC survivors.2,5,6 Obesity has been linked to both higher mortality and an 
increased risk for colon cancer recurrence,7,8 and lifetime heavy tobacco use (≥20 pack-year 
history) has been shown to negatively affect years of disease-free survival.9 Conversely, 
engaging in physical activity can increase years of disease-free survival.6
Several population-based studies have assessed the characteristics of cancer survivors,10–14 
but few focus primarily on CRC survivors.15 This article describes, at the population level, 
the demographics, comorbid health conditions, health behaviors, health care access, use of 
preventive health services, and health-related quality of life (HRQOL) of CRC survivors to 
help public health practitioners and health care clinicians prioritize CRC cancer survivorship 
interventions. Additionally, this study compared CRC survivors with other cancer survivors 
and persons without cancer to ascertain whether CRC survivors had unique needs that could 
be addressed in interventions.
Methods
Behavioral Risk Factor Surveillance System Survey
This study used the Behavioral Risk Factor Surveillance System (BRFSS), a state-based 
system of health surveys that collects information on health risk behaviors, preventive health 
practices, and health care access through a cross-sectional, random-digit–dialed telephone 
survey of noninstitutionalized adults aged 18 years or older, using trained interviewers and 
standard core and optional questionnaire modules. Surveys are conducted with US state and 
territorial households each month.16–18
Survey respondents were asked if they had ever been told by a doctor, nurse, or other health 
care professional that they had cancer. If they answered yes, they were asked how many 
different types of cancer they had, age at diagnosis for their first cancer, and the cancer type 
(most recently diagnosed cancer site if >1 diagnosis was reported). Detailed methodology 
regarding the cancer survivorship modules has been described elsewhere.11 We excluded 
respondents who had an unknown cancer history or refused to answer the question 
(n=5057), or who reported their most recent cancer as nonmelanoma skin cancer 
(n=16,497).
Data Preparation
We combined survey years 2009 and 2010 in the final analytic file to increase the CRC 
survivor sample size. In the 2009 BRFSS survey, cancer survivorship questions were 
administered by all states, the District of Columbia (DC), and territories. In 2010, 17 states 
(Alaska, California, Colorado, Connecticut, Indiana, Iowa, Massachusetts, Michigan, 
Missouri, New Jersey, New Mexico, Ohio, Oklahoma, South Dakota, Texas, Utah, and 
Wisconsin) and Guam administered the module. For states included in both survey years, 
survey weights were adjusted to prevent overrepresentation of these states on prevalence 
estimates. A subset of 23 states was included in the analysis of CRC screening because 8 
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states in 2009 included CRC screening on their BRFSS questionnaire, but all states, DC, and 
Guam had CRC screening questions in 2010. Three states had both the 2009 screening 
questions and the 2010 survivorship module, whereas 5 states included the screening 
questions in 2009 but did not run the survivorship module in 2010. Therefore, this analysis 
included 71,720 respondents aged 50 to 75 years who answered questions regarding CRC 
screening. Similarly, 5 states included questions in 2009 on mammography use, but all 
states, DC, and territories had them in 2010. This analysis included 39,560 female 
respondents aged 50 to 74 years from 22 states.
Variables
We compared CRC survivors with other cancer survivors and respondents without a history 
of cancer, examining the following demographic characteristics: age at interview, sex, 
racial/ethnic background, marital status, education level, census region of residence, 
employment status, health insurance coverage, and inability to see a doctor because of cost. 
For CRC and other cancer survivors, we calculated years since diagnosis using the 
respondents' current age and age at first cancer diagnosis.
We examined the following health behaviors: current smoking status, binge drinking (men 
having ≥5 and women having ≥4 alcoholic drinks on one occasion in the past month), 
obesity (body mass index ≥30 kg/m2), and no leisure-time physical activity in the past 
month. We analyzed the following chronic health conditions: cardiovascular disease (CVD); 
disability from physical, mental, and emotional problems; current asthma; and history of 
diabetes (not including gestational diabetes). We also examined health care access variables: 
having a personal health care provider and a routine checkup in the past 2 years. We 
analyzed receipt of preventive health services: pneumococcal vaccine, influenza vaccine 
within the past 12 months, recommended CRC screening test, and mammography for breast 
cancer screening within the past 2 years for women aged 50 to 74 years. The surveillance 
recommendation for CRC survivors is at 1 and 3 years postoperatively, then every 5 years 
thereafter,19,20 so we restricted our assessment of routine CRC surveillance to CRC 
survivors (aged 50–75 years) diagnosed 5 or more years ago. For other cancer survivors and 
persons without cancer, we assessed whether they met US Preventive Services Task Force 
guidelines for CRC screening. To be considered up-to-date, both groups aged 50 to 75 years 
must have had either a fecal occult blood test (FOBT) within the past year, sigmoidoscopy 
within the past 5 years and an FOBT in the past 3 years, or colonoscopy within the past 10 
years.
The following indicators were used to measure HRQOL21: health status and the CDC 
Healthy Days measures. As part of the Healthy Days measures, survey respondents were 
asked how many days during the past 30 days they experienced poor physical and mental 
health. Respondents who indicated 1 or more days on either question were then asked how 
many days was their usual activity limited by poor physical or mental health. All 3 variables 
were categorized as either 0 to 13 days or 14 or more days during the past 30 days. Receipt 
of social support and overall life satisfaction variables were also examined to get a broader 
picture of the well-being of CRC survivorship.
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SAS Version 9.2 (SAS Institute, Cary, NC) and SAS-callable SUDAAN release 10 (RTI 
International, Research Triangle Park, NC) were used to account for the complex sampling 
design of the BRFSS and to provide weighted population estimates.18 A descriptive analysis 
was first conducted to obtain weighted prevalence estimates with 95% CIs for demographic 
characteristics, risk behaviors, chronic medical conditions, preventive medical care, life 
satisfaction, social support, and HRQOL among CRC survivors, other cancer survivors, and 
respondents without a history of cancer. P values were calculated using the Wald F test. 
Comparisons were made directly between CRC survivors and persons without cancer, and 
between CRC survivors and other cancer survivors.
A multivariable logistic regression was conducted to control for demographic characteristics 
and health care access on the following outcomes of interest: general health status, receipt of 
social support, life satisfaction, current smoking status, binge drinking, obesity, no leisure-
time physical activity, CVD, disability, current asthma, diabetes, CRC screening, 
mammography test use, influenza vaccination, pneumococcal vaccination, 14 or more 
mentally unhealthy days, 14 or more physically unhealthy days, and 14 or more days in 
which poor health limited usual activities. In each of these models, CRC survivors and other 
cancer survivors were compared with respondents without a history of cancer (referent 
group) and adjusted for the following covariates: age, sex, education, race/ethnicity, marital 
status, health insurance coverage, census region, and employment status. Because more than 
one outcome for health status and receipt of social support was assessed, multinomial 
logistic regression was used in these models. The no leisure-time physical activity model 
also adjusted for activity limitations caused by health problems, and the CRC screening 
model included having a usual health care provider as a covariate (because this variable is a 
strong predictor of screening). Health status was also included in the influenza and 
pneumococcal vaccination models. The mammography screening model was adjusted for 
education, race/ethnicity, marital status, health insurance coverage, employment status, 
health status, census region, and usual health care provider.
Results
Of the survey respondents included in this analysis, 436,620 said they had never been 
diagnosed with cancer, 52,788 reported being survivors of other cancers (primarily breast, 
prostate, and melanoma), and 4001 said they were CRC survivors (Table 1, available online, 
in this article, at JNCCN.org). Compared with both other cancer survivors and respondents 
without cancer, CRC survivors tended to be older and retired, and to have access to health 
insurance. CRC survivors also tended to be more recently diagnosed than other cancer 
survivors.
CRC survivors were more likely to be obese than other cancer survivors and respondents 
without cancer (29.1% vs 27.5% and 26.8%; P=.0003 and P<.0001, respectively) and 
reported having no leisure-time physical activity (34.2% vs 31.0% and 23.8%; P=.044 and 
P<.0001, respectively) (Table 2, available online, in this article, at JNCCN.org). CRC 
survivors reported being current smokers less often than other cancer survivors and persons 
without cancer (11.1% vs 15.3% and 17.9%, respectively; P<.0001). CRC survivors more 
Rohan et al. Page 4









frequently reported having CVD (22.3% vs 17.9% and 16.4%, respectively; P<.0001) and 
diabetes (20.9% vs 6.8% and 8.3%; P=.0002 and P<.0001, respectively) than other cancer 
survivors and persons without cancer. CRC survivors were more likely to report having a 
personal health care provider (95.3% vs 93.4% and 80.2%; P=.007 and P<.0001, 
respectively) and having had a regular checkup more recently (93.0% vs 89.6% and 80.7%; 
P<.0001) than other cancer survivors and persons without cancer, respectively. CRC 
survivors also more frequently reported being up-to-date with vaccinations for influenza 
(61.4% vs 57.4% and 36.2%; P<.0001) and pneumonia (54.7% vs 48.1% and 20.9%; P=.
039 and P<.0001, respectively). CRC survivors were more likely to have undergone 
mammography screenings than respondents without a history of cancer (85.1% vs 78.1%; 
P=.031). Among long-term survivors (>5 years postdiagnosis), CRC survivors reported 
undergoing colonoscopic surveillance according to posttreatment guidelines appropriate for 
their cancer history more frequently (87.4%) than respondents without cancer reported being 
appropriately screened for CRC (59.4%; P<.0001).
A higher percentage of CRC survivors reported fair, as opposed to good or excellent, overall 
health compared with other cancer survivors (22.3% vs 19.2%; P<.0001; Table 3, available 
online, in this article, at JNCCN.org). CRC survivors were more likely than other survivors 
to report 13 or fewer days of poor mental health in the past 30 days (87.8% vs 85.2%; P=.
022). CRC survivors were also more likely than respondents without cancer to report more 
days of poor physical health (23.5% vs 9.8%; P<.0001), including poor health that limited 
activity (24.0% vs 12.3%; P<.0001), in the past 30 days. CRC survivors were more likely 
than respondents without cancer to report “always” receiving needed social support (51.4% 
vs 48.1%; P=.0003).
Adjusted results (Table 4, available online, in this article, at JNCCN.org) show that CRC 
survivors were 20% less likely to be a current smoker (odds ratio [OR], 0.80; 95% CI, 0.66–
0.98) than respondents without cancer. CRC survivors were also 17% more likely to report 
not engaging in leisure-time physical activity (OR, 1.17; 95% CI, 1.01–1.34) than 
respondents without cancer.
CRC survivors were approximately 30% more likely to have CVD (OR, 1.35; 95% CI, 
1.17–1.56) or current asthma (OR, 1.31; 95% CI, 1.03–1.65), or to have ever been told they 
had diabetes (OR, 1.33; 95% CI, 1.14–1.56) than respondents without cancer. CRC 
survivors were also 76% more likely to report having activity limitations than respondents 
without cancer (OR, 1.76; 95% CI, 1.53–2.03). CRC survivors were more likely to receive 
mammography and vaccinations for influenza and pneumonia compared with respondents 
without cancer, and were 2.7 times more likely than other cancer survivors to be up-to-date 
with CRC screening than other cancer survivors (OR, 2.71; 95% CI, 1.44–5.10).
CRC survivors were more likely than respondents without cancer to be in fair/poor or good 
health versus excellent/very good health (OR, 3.02; 95% CI, 2.58–3.53, and OR, 1.95, 95% 
CI, 1.66– 2.29, respectively). CRC survivors were 1.5 times as likely to report being 
dissatisfied/very dissatisfied versus satisfied/very satisfied with life (OR, 1.47; 95% CI, 
1.05–2.05) compared with respondents without cancer. Additionally, CRC survivors were 
27% more likely to have had poor mental health (OR, 1.27; 95% CI, 1.05–1.53), nearly 
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twice as likely to have had poor physical health (OR, 1.91; 95% CI, 1.64–2.21), and 62% 
more likely to have had activity limitations because of poor health within the past 30 days 
(OR, 1.62, 95% CI, 1.34–1.96) compared with respondents without cancer.
The pattern of the adjusted results was similar among CRC survivors and other cancer 
survivors compared with those without cancer for all variables, except for smoking status. 
CRC survivors had significantly lower smoking levels (OR, 0.80; 95% CI, 0.66–0.98) than 
respondents without cancer, whereas those with other cancers have significantly higher 
smoking levels (OR, 1.09; 95% CI, 1.02–1.15).
Discussion
The adjusted results show that CRC survivors were not significantly different from other 
cancer survivors, but they were significantly different from respondents without cancer. 
Specifically, CRC survivors had more comorbidities, were less physically active, and had 
poorer HRQOL than respondents without cancer.
That CRC survivors were more likely to have CVD, current asthma, or a history of diabetes 
than respondents without cancer is concerning; studies have shown that CRC survivors are 
less likely to receive recommended care for cardiac and other chronic conditions,22 and that 
noncancer comorbidities have a greater influence on quality of life for long-term (>5 years 
since diagnosis) CRC survivors than either stage at diagnosis or time since diagnosis.23 The 
findings support the need for improved care of comorbid conditions among CRC survivors 
and survivors of other cancers.
CRC survivors were less likely to be current smokers than those without cancer, which is 
important in promoting their long-term survival. However, CRC survivors reported a lack of 
physical activity. This is an important area for intervention for CRC survivors, especially 
because physical inactivity is a risk factor for (precancerous) adenomatous colorectal 
polyps,24 other cancers, and other chronic diseases, such as heart disease.
In terms of routine medical care, medical follow-up, and receiving preventive care, such as 
vaccinations for influenza and pneumococcus, CRC survivors reported better outcomes than 
other cancer survivors and respondents without cancer. This could be because CRC 
survivors were more recently diagnosed than other cancer survivors in this study and, 
therefore, more likely to be under close medical supervision. Still, this finding differs from 
an earlier study of Medicare claims data22 that found CRC survivors to be less likely to 
undergo routine preventive care, such as influenza vaccination, than matched controls 
without cancer. Because the data reported here are more recent than the Medicare study, this 
difference may reflect a positive trend in increased use of preventive services by CRC 
survivors. In support of this, the findings also show that CRC survivors are more likely to be 
up-to-date on breast cancer screening than those without cancer and are generally receiving 
appropriate colonoscopy surveillance. These positive health behaviors should continue to be 
reinforced by health care providers.
The poor health status reported by CRC survivors may be related to surgical interventions, 
chemotherapy, or radiation performed as part of treatment. The findings regarding poor 
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mental health in CRC survivors are consistent with those of other studies of CRC survivors 
that report depression as more prevalent in this population.23 This was particularly evident 
for CRC survivors diagnosed less than 5 years ago, who had a higher prevalence of poor 
health status and more days of poor mental and physical health (data not shown) compared 
with longer-term CRC survivors.
The negative issues experienced by CRC survivors reported in this study may be addressed 
by chronic disease self-management, a promising practice being examined in the context of 
oncology.25 Self-management is facilitated by patient-centered survivorship care planning, 
including the development and use of a survivorship care plan, which is a written, 
comprehensive treatment summary and plan for follow-up care.26 Programs such as the 
CDC's National Comprehensive Cancer Control Program have prioritized cancer 
survivorship care and resources.27 These programs work within local communities to 
promote interventions that adequately address the needs of all survivors.
Strengths and Limitations
This study has several strengths. The BRFSS is a well-established, population-based survey 
that incorporates activities to help ensure that quality data are collected in a manner usable 
by public health practitioners. In using BRFSS in this study, we have conducted the largest 
population-based health behavior analysis of CRC survivors to our knowledge to date. This 
study also has several limitations. As with all self-reported data, the findings may be limited 
by recall and social desirability biases. Although BRFSS survey methodology has recently 
expanded to include cellular telephones, the surveys used for this report were limited to 
landline telephones (www.cdc.gov/brfss/about/brfss_today.htm). BRFSS also excludes 
individuals who are incarcerated or hospitalized, or who reside in institutions, such as 
nursing homes or inpatient hospice units, which may mean that cancer survivors with more 
advanced disease are not represented.
Conclusions
CRC survivors' lives are significantly affected by their illness. The findings can help public 
health professionals and health care practitioners develop tailored information to address the 
common occurrence of comorbidities, including the negative effects these can have on 
quality of life, and interventions, such as appropriate physical activity programs, that may 
help alleviate these effects. This development can occur through a multidisciplinary 
approach that includes physicians, nurses, social workers, nutritionists, and exercise 
therapists. The information and interventions developed would likely benefit survivors of 
other cancers as well.
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